RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY.